Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Category: Drugs
Remove filter for
Issue: Labelling
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 15 of 15 items.
Life Brand Long Lasting Decongestant Nasal Spray 15 mL: Labelled with incorrect Drug Facts Table
RecallHealth product recall | 2024-01-04
Life Brand Decongestant Nasal Spray 20 mL: Labelled with incorrect Drug Facts Table
RecallHealth product recall | 2024-01-04
Micafungin Sodium for Injection 50 mg/vial and 100 mg/vial: Linear barcode printed on the vial label is non-functioning
RecallHealth product recall | 2023-08-21
Dexmedetomidine Hydrochloride Injection: illegible lot number and expiry date on label
RecallHealth product recall | 2023-08-09
JAMP Venlafaxine XR 37.5 mg capsules; Mislabelling
RecallHealth product recall | 2023-06-22
Solarcaine first aid spray; Labelling issue
RecallHealth product recall | 2023-05-05
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer
AlertPublic advisory | 2022-11-01
POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION: Affected lot is labelled with the incorrect strength and ingredient
RecallHealth product recall | 2022-10-24
JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.
RecallHealth product recall | 2022-08-29
PMS-Hydromorphone: Affected lot may contain tablets that could potentially lead to overdose
RecallHealth product recall | 2022-08-22
Recall of one lot of pms-Hydromorphone due to packaging error that could potentially lead to overdose
AlertPublic advisory | 2022-08-20
Distribution of EVUSHELD (tixagevimab and cilgavimab for injection) with English-Only Vial and Carton Labels
AlertHealth professional risk communication | 2022-04-14
Distribution of NUVAXOVID with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2022-02-23
PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
AlertHealth professional risk communication | 2022-01-17